• Published 2007

JNCCN NCCN Task Force Report : Optimal Management of Patients with Gastrointestinal Stromal Tumor ( GIST ) — Update of the NCCN Clinical Practice Guidelines

@inproceedings{Demetri2007JNCCNNT,
  title={JNCCN NCCN Task Force Report : Optimal Management of Patients with Gastrointestinal Stromal Tumor ( GIST ) — Update of the NCCN Clinical Practice Guidelines},
  author={George D. Demetri and Robert S Benjamin and Charles David Blanke and Jean-Yves Blay and Paolo Giovanni Casali and Haesun Choi and Christopher L. Corless and M Debiecrychter and Ronald P. DeMatteo and David S. Ettinger and George A. Fisher and Christopher D. M. Fletcher and Alessandro Gronchi and Peter Hohenberger and Miranda Hughes and Heikki Joensuu and Ian Judson and Axel Le Cesne and Robert G. Maki and Michael Morse and Alberto Pappo and Peter W. T. Pisters and Chandrajit P Raut and Peter Reichardt and Douglas S. Tyler and A. Van Den Abbeele and Margaret von Mehren and John Zalcberg},
  year={2007}
}
The NCCN Soft Tissue Sarcoma Guidelines include a subsection about treatment recommendations for gastrointestinal stromal tumors (GISTs). The standard of practice rapidly changed after the introduction of effective molecularly targeted therapy (such as imatinib and sunitinib) for GIST. Because of these changes, NCCN organized a multidisciplinary panel composed of experts in the fields of medical oncology, molecular diagnostics, pathology, radiation oncology, and surgery to discuss the optimal… CONTINUE READING

Citations

Publications citing this paper.
SHOWING 1-10 OF 22 CITATIONS

Unusual features of gastrointestinal stromal tumor on PET/CT and CT imaging.

  • Clinical nuclear medicine
  • 2011
VIEW 14 EXCERPTS
CITES BACKGROUND
HIGHLY INFLUENCED

GASTROINTESTINAL STROMAL TUMOR IN A YOUNG MAN WITH SEVERE HEMATEMESIS: A CASE STUDY.

  • Gastroenterology nursing : the official journal of the Society of Gastroenterology Nurses and Associates
  • 2016
VIEW 1 EXCERPT
CITES BACKGROUND

Long-term Outcomes of Submucosal Tunneling Endoscopic testinal Submucosal Tumors Resection for Upper Gastroin

Tao Chen, Ping-Hong Zhou, +5 authors Mei-Dong Xu
  • 2016
VIEW 1 EXCERPT
CITES BACKGROUND

References

Publications referenced by this paper.
SHOWING 1-10 OF 116 REFERENCES

Gastrointestinal stromal tumors: pathology and prognosis at different sites.

  • Seminars in diagnostic pathology
  • 2006
VIEW 4 EXCERPTS
HIGHLY INFLUENTIAL

Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors

G Demetri, M von Mehren, C Blanke
  • N Engl J Med
  • 2002
VIEW 6 EXCERPTS
HIGHLY INFLUENTIAL

Gastrointestinal cancer.

VIEW 7 EXCERPTS
HIGHLY INFLUENTIAL

Efficacy of the kinase inhibitor SU11248 against gastrointestinal stromal tumor mutants refractory to imatinib mesylate.

  • Clinical cancer research : an official journal of the American Association for Cancer Research
  • 2006
VIEW 3 EXCERPTS
HIGHLY INFLUENTIAL